| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CG Oncology, Inc. | CFO | Common Stock | 2K | $70.7K | $35.36 | Jan 29, 2024 | Direct |
| CG Oncology, Inc. | CFO | Stock Option (Right to Buy) | 93.6K | Oct 4, 2024 | Direct | ||
| Immunome Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 58K | Jun 8, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | Oct 4, 2024 | 1 | $0 | 4 | Oct 8, 2024 | CFO |
| CGON | CG Oncology, Inc. | Jan 29, 2024 | 1 | $38K | 4 | Jan 31, 2024 | CFO & Secretary |
| CGON | CG Oncology, Inc. | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | CFO & Secretary |
| CGON | CG Oncology, Inc. | Jan 24, 2024 | 0 | $0 | 3 | Jan 24, 2024 | CFO & Secretary |
| IMNM | Immunome Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Chief Financial Officer |
| IMNM | Immunome Inc. | Jun 16, 2022 | 1 | $0 | 4 | Jun 21, 2022 | Chief Financial Officer |
| IMNM | Immunome Inc. | May 28, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Chief Financial Officer |